SPOTLIGHT -
FDA Approves Jardiance for Patients with Chronic Kidney Disease
Jardiance is currently available to treat patients with type 2 diabetes, end stage renal disease and heart failure. It has a list price of $570.48 for a month supply.
New Illinois Law Promotes PBM Transparency
Illinois Governor JB Pritzker signed into law a bill prohibiting PBM retaliation against pharmacists who disclose information during government proceedings.
Out-of-Pocket Costs Impact Medication Access for Some Medicare Beneficiaries with Schizophrenia
Low-income subsidies can eliminate much of the out-of-pocket costs that patients must pay.
Cost Savings Associated with Therapeutic Exchange of Stimulant Medications
Cost savings were not associated with an increase in adverse drug events.
